vs

Side-by-side financial comparison of Delek US Holdings, Inc. (DK) and Edwards Lifesciences (EW). Click either name above to swap in a different company.

Delek US Holdings, Inc. is the larger business by last-quarter revenue ($2.4B vs $1.6B, roughly 1.5× Edwards Lifesciences). Edwards Lifesciences runs the higher net margin — 23.1% vs 3.2%, a 19.9% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs 2.3%). Over the past eight quarters, Edwards Lifesciences's revenue compounded faster (9.7% CAGR vs -11.9%).

Delek US Holdings, Inc. is an oil refining, logistics and biofuels company founded in 2001 and headquartered in Brentwood, Tennessee.

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

DK vs EW — Head-to-Head

Bigger by revenue
DK
DK
1.5× larger
DK
$2.4B
$1.6B
EW
Growing faster (revenue YoY)
EW
EW
+14.4% gap
EW
16.7%
2.3%
DK
Higher net margin
EW
EW
19.9% more per $
EW
23.1%
3.2%
DK
Faster 2-yr revenue CAGR
EW
EW
Annualised
EW
9.7%
-11.9%
DK

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DK
DK
EW
EW
Revenue
$2.4B
$1.6B
Net Profit
$78.3M
$380.7M
Gross Margin
9.3%
78.0%
Operating Margin
6.8%
1.8%
Net Margin
3.2%
23.1%
Revenue YoY
2.3%
16.7%
Net Profit YoY
118.9%
6.8%
EPS (diluted)
$1.23
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DK
DK
EW
EW
Q1 26
$1.6B
Q4 25
$2.4B
$1.6B
Q3 25
$2.9B
$1.6B
Q2 25
$2.8B
$1.5B
Q1 25
$2.6B
$1.4B
Q4 24
$2.4B
$1.4B
Q3 24
$3.0B
$1.4B
Q2 24
$3.3B
$1.4B
Net Profit
DK
DK
EW
EW
Q1 26
$380.7M
Q4 25
$78.3M
$91.2M
Q3 25
$178.0M
$291.1M
Q2 25
$-106.4M
$333.2M
Q1 25
$-172.7M
$358.0M
Q4 24
$-413.8M
$385.6M
Q3 24
$-76.8M
$3.1B
Q2 24
$-37.2M
$366.3M
Gross Margin
DK
DK
EW
EW
Q1 26
78.0%
Q4 25
9.3%
78.1%
Q3 25
13.8%
77.8%
Q2 25
1.9%
77.5%
Q1 25
-2.4%
78.7%
Q4 24
-5.7%
78.9%
Q3 24
-0.7%
80.6%
Q2 24
0.5%
79.9%
Operating Margin
DK
DK
EW
EW
Q1 26
1.8%
Q4 25
6.8%
9.6%
Q3 25
10.2%
19.8%
Q2 25
-1.2%
26.8%
Q1 25
-4.8%
27.9%
Q4 24
-17.0%
22.6%
Q3 24
-4.0%
25.9%
Q2 24
0.1%
26.8%
Net Margin
DK
DK
EW
EW
Q1 26
23.1%
Q4 25
3.2%
5.8%
Q3 25
6.2%
18.7%
Q2 25
-3.8%
21.7%
Q1 25
-6.5%
25.3%
Q4 24
-17.4%
27.8%
Q3 24
-2.5%
226.7%
Q2 24
-1.1%
26.7%
EPS (diluted)
DK
DK
EW
EW
Q1 26
$0.66
Q4 25
$1.23
$0.16
Q3 25
$2.93
$0.50
Q2 25
$-1.76
$0.56
Q1 25
$-2.78
$0.61
Q4 24
$-6.48
$0.65
Q3 24
$-1.20
$5.13
Q2 24
$-0.58
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DK
DK
EW
EW
Cash + ST InvestmentsLiquidity on hand
$625.8M
Total DebtLower is stronger
$3.2B
Stockholders' EquityBook value
$547.3M
Total Assets
$6.8B
Debt / EquityLower = less leverage
5.91×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DK
DK
EW
EW
Q1 26
Q4 25
$625.8M
$4.2B
Q3 25
$630.9M
$3.8B
Q2 25
$615.5M
$4.1B
Q1 25
$623.8M
$3.9B
Q4 24
$735.6M
$4.0B
Q3 24
$1.0B
$4.4B
Q2 24
$657.9M
$2.0B
Total Debt
DK
DK
EW
EW
Q1 26
Q4 25
$3.2B
Q3 25
$3.2B
Q2 25
$3.1B
Q1 25
$3.0B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$2.5B
Stockholders' Equity
DK
DK
EW
EW
Q1 26
Q4 25
$547.3M
$10.3B
Q3 25
$444.8M
$10.2B
Q2 25
$294.9M
$10.5B
Q1 25
$429.4M
$10.1B
Q4 24
$575.2M
$10.0B
Q3 24
$875.4M
$9.5B
Q2 24
$982.8M
$7.4B
Total Assets
DK
DK
EW
EW
Q1 26
Q4 25
$6.8B
$13.7B
Q3 25
$7.1B
$13.3B
Q2 25
$7.1B
$13.5B
Q1 25
$6.9B
$13.0B
Q4 24
$6.7B
$13.1B
Q3 24
$7.0B
$13.0B
Q2 24
$6.9B
$10.1B
Debt / Equity
DK
DK
EW
EW
Q1 26
Q4 25
5.91×
Q3 25
7.14×
Q2 25
10.51×
Q1 25
7.07×
Q4 24
4.81×
Q3 24
3.19×
Q2 24
2.50×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DK
DK
EW
EW
Operating Cash FlowLast quarter
$502.8M
Free Cash FlowOCF − Capex
$382.8M
FCF MarginFCF / Revenue
15.8%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
6.42×
TTM Free Cash FlowTrailing 4 quarters
$6.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DK
DK
EW
EW
Q1 26
Q4 25
$502.8M
$450.9M
Q3 25
$44.0M
$573.7M
Q2 25
$51.4M
$290.2M
Q1 25
$-62.4M
$280.4M
Q4 24
$-163.5M
$-127.5M
Q3 24
$-21.6M
$351.8M
Q2 24
$-48.4M
$371.5M
Free Cash Flow
DK
DK
EW
EW
Q1 26
Q4 25
$382.8M
$353.5M
Q3 25
$-64.0M
$516.2M
Q2 25
$-114.4M
$240.9M
Q1 25
$-198.1M
$224.4M
Q4 24
$-354.0M
$-177.3M
Q3 24
$-140.6M
$299.9M
Q2 24
$-128.3M
$286.1M
FCF Margin
DK
DK
EW
EW
Q1 26
Q4 25
15.8%
22.5%
Q3 25
-2.2%
33.2%
Q2 25
-4.1%
15.7%
Q1 25
-7.5%
15.9%
Q4 24
-14.9%
-12.8%
Q3 24
-4.6%
22.1%
Q2 24
-3.9%
20.9%
Capex Intensity
DK
DK
EW
EW
Q1 26
Q4 25
4.9%
6.2%
Q3 25
3.7%
3.7%
Q2 25
6.0%
3.2%
Q1 25
5.1%
4.0%
Q4 24
8.0%
3.6%
Q3 24
3.9%
3.8%
Q2 24
2.4%
6.2%
Cash Conversion
DK
DK
EW
EW
Q1 26
Q4 25
6.42×
4.94×
Q3 25
0.25×
1.97×
Q2 25
0.87×
Q1 25
0.78×
Q4 24
-0.33×
Q3 24
0.11×
Q2 24
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DK
DK

Refining$2.2B91%
Other$173.0M7%
Gravity Water Intermediate Holdings LLC Gravity$22.5M1%
Related Party$20.8M1%
Logistics$1.3M0%

EW
EW

Segment breakdown not available.

Related Comparisons